Tumor biopsy and patient enrollment in clinical trials for advanced hepatocellular carcinoma

Tumor biopsy and patient enrollment in clinical trials for advanced hepatocellular carcinoma

Tumor biopsies may help to reliably distinguish hepatocellular carcinoma (HCC) from other tumors, mostly cholangiocarcinoma as well as to identify the patient populations who most benefit from target-driven HCC treatments, in order to improve the success rate of experimental therapies. Clarifying tu...

Full description

Bibliographic Details
Main Authors: Rimassa, Lorenza, Reig, Maria, Abbadessa, Giovanni, Peck-Radosavljevic, Markus, Harris, William, Zagonel, Vittorina, Pastorelli, Davide, Rota Caremoli, Elena, Porta, Camillo, Damjanov, Nevena, Patel, Hitendra, Daniele, Bruno, Lamar, Maria, Schwartz, Brian, Goldberg, Terri, Santoro, Armando, Bruix, Jordi
Other Authors: Univ Arizona, Ctr Canc, Dept Med
Language:en
Published: BAISHIDENG PUBLISHING GROUP INC 2017
Subjects:
Liver neoplasms
Biopsy
Biomarkers
Clinical trial
Tumor
Online Access:http://hdl.handle.net/10150/626013
http://arizona.openrepository.com/arizona/handle/10150/626013

Internet

http://hdl.handle.net/10150/626013
http://arizona.openrepository.com/arizona/handle/10150/626013

Similar Items